SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001306923-22-000013
Filing Date
2022-02-14
Accepted
2022-02-14 17:11:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 epizyme.txt SC 13G/A 10130
  Complete submission text file 0001306923-22-000013.txt   11698
Mailing Address 470 UNIVERSITY AVE PALO ALTO CA 94301
Business Address 470 UNIVERSITY AVE PALO ALTO CA 94301 650-325-0772
Palo Alto Investors LP (Filed by) CIK: 0001306923 (see all company filings)

IRS No.: 770558164 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Subject) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87481 | Film No.: 22634619
SIC: 2834 Pharmaceutical Preparations